Minimal residual disease monitoring in multiple myeloma: flow cytometry is the method of choice.
作者信息
Owen Roger G, Rawstron Andy C
出版信息
Br J Haematol. 2005 Mar;128(5):732-3; author reply 733-4. doi: 10.1111/j.1365-2141.2005.05376.x.
Abstract
摘要
Owen Roger G, Rawstron Andy C
Br J Haematol. 2005 Mar;128(5):732-3; author reply 733-4. doi: 10.1111/j.1365-2141.2005.05376.x.
Zotero 插件